[
  {
    "ts": null,
    "headline": "Is BD’s (BDX) Expanded European Diagnostics Menu Quietly Reshaping Its Competitive Moat?",
    "summary": "BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR certification of two Certest Biotec VIASURE assays for the fully automated BD MAX™ System, covering a wide range of respiratory and sexually transmitted pathogens from streamlined sample workflows. This broadening of the BD MAX™ assay menu deepens BD’s role in high-throughput molecular testing, strengthening its position in hospital and clinical laboratory workflows that rely...",
    "url": "https://finnhub.io/api/news?id=8b430e48b43ae03309d0044896b249203b809fa02ff871ea2ad12ed045c91cf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765919212,
      "headline": "Is BD’s (BDX) Expanded European Diagnostics Menu Quietly Reshaping Its Competitive Moat?",
      "id": 137806690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR certification of two Certest Biotec VIASURE assays for the fully automated BD MAX™ System, covering a wide range of respiratory and sexually transmitted pathogens from streamlined sample workflows. This broadening of the BD MAX™ assay menu deepens BD’s role in high-throughput molecular testing, strengthening its position in hospital and clinical laboratory workflows that rely...",
      "url": "https://finnhub.io/api/news?id=8b430e48b43ae03309d0044896b249203b809fa02ff871ea2ad12ed045c91cf3"
    }
  },
  {
    "ts": null,
    "headline": "Is Becton Dickinson Now an Opportunity After Diagnostics Expansion and 2026 Business Separation Plans?",
    "summary": "If you have been wondering whether Becton Dickinson is quietly turning into a value opportunity or just a value trap, you are not alone. This breakdown is designed to give you a clear, no jargon view of where the stock really stands. The share price has bounced 5.6% over the last week and 3.7% over the past month, even though it is still down 11.7% year to date and 10.2% over the last year. This mix often signals shifting expectations around growth and risk. Recent headlines have focused on...",
    "url": "https://finnhub.io/api/news?id=bd5c3d5f3620f2105210afea38c4bfb670de75f0bf5cb20192b43f63de4c2bf6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765912191,
      "headline": "Is Becton Dickinson Now an Opportunity After Diagnostics Expansion and 2026 Business Separation Plans?",
      "id": 137806691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "If you have been wondering whether Becton Dickinson is quietly turning into a value opportunity or just a value trap, you are not alone. This breakdown is designed to give you a clear, no jargon view of where the stock really stands. The share price has bounced 5.6% over the last week and 3.7% over the past month, even though it is still down 11.7% year to date and 10.2% over the last year. This mix often signals shifting expectations around growth and risk. Recent headlines have focused on...",
      "url": "https://finnhub.io/api/news?id=bd5c3d5f3620f2105210afea38c4bfb670de75f0bf5cb20192b43f63de4c2bf6"
    }
  },
  {
    "ts": null,
    "headline": "BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe",
    "summary": "BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.",
    "url": "https://finnhub.io/api/news?id=0d4bfe8e1b850ebd0d377841555219cb6aa0c90ac33c6a0cb9a410d2de9b162d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765903020,
      "headline": "BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe",
      "id": 137806692,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BDX expands its BD MAX menu in Europe with IVDR-approved respiratory and STI assays, boosting system utility and reinforcing its diagnostics growth strategy.",
      "url": "https://finnhub.io/api/news?id=0d4bfe8e1b850ebd0d377841555219cb6aa0c90ac33c6a0cb9a410d2de9b162d"
    }
  },
  {
    "ts": null,
    "headline": "PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors",
    "summary": "Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P",
    "url": "https://finnhub.io/api/news?id=9151c2dd5d5d9bba108cc7b97ffdf8c0516a7adbb5aaa05462336e4bc46fc7ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765891800,
      "headline": "PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors",
      "id": 137806455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P",
      "url": "https://finnhub.io/api/news?id=9151c2dd5d5d9bba108cc7b97ffdf8c0516a7adbb5aaa05462336e4bc46fc7ed"
    }
  }
]